Friday 6 November 2026
Export PMI’s income statement to Excel — free account
Flag Ship Acquisition Corp
PMI Healthcare Medical Devices
Flag Ship Acquisition Corp’s revenue for fiscal 2025 (year ended December 2025) was $4.9 million, up 12.5% from fiscal 2024.
- Revenue
- +38.6%
- EPS
- +92.8%
- Free cash flow
- +46.8%
- Total debt
- −89.8%
Quarter to June 2026, against a year earlier
9.00
1.15
+14.65%
Follow PMI
Alert me
Target Price Range
Analyst price targets
Free accountTen years at a glance Fiscal years to December
| Ten-year view | Analyst estimates Powerpack | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Group | Line | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM Jun ’26 | Trend | 10 yrs | 2026e | 2027e | 2028e | Next 3/yr |
| Income, $m | ||||||||||||||||||
| Income, $m | Revenue | — | — | — | — | — | — | — | — | 4 | 5 | 6 | +12.5% | 49 | 44 | 49 | +114.3% | |
| Gross margin, % | — | — | — | — | — | — | — | — | (2.55) | (4.13) | 18.62 | (1.6) pt | ||||||
| EBT | — | — | — | — | — | — | — | — | (21) | (27) | (28) | +28.0% | ||||||
| EBT margin, % | — | — | — | — | — | — | — | — | (479.85) | (545.89) | (444.65) | (66.0) pt | ||||||
| Net income | — | — | — | — | — | — | — | — | (21) | (27) | (28) | +28.2% | ||||||
| Per share, $ | ||||||||||||||||||
| Per share, $ | Revenue | — | — | — | — | — | — | — | — | 27.63 | 6.82 | 3.39 | (75.3%) | |||||
| Earnings | — | — | — | — | — | — | — | — | (149.50) | (37.50) | (20.46) | (74.9%) | ||||||
| Cash flow | — | — | — | — | — | — | — | — | (74.73) | (21.63) | (8.64) | (71.1%) | ||||||
| Capex | — | — | — | — | — | — | — | — | 0.00 | 0.00 | 0.00 | n/m | ||||||
| Free cash flow | — | — | — | — | — | — | — | — | (74.73) | (21.63) | (8.64) | (71.1%) | ||||||
| Book value | — | — | — | — | — | — | — | — | (149.38) | 5.23 | 0.92 | n/m | ||||||
| Shares, m | — | — | — | — | — | — | — | — | 0 | 1 | 1 | +356.1% | ||||||
| Valuation, × | ||||||||||||||||||
| Valuation, × | P/E | — | — | — | — | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.0 | |||||
| P/S | — | — | — | — | — | — | — | — | 9.41 | 12.84 | 2.65 | 11.1 | ||||||
| P/B | — | — | — | — | — | — | — | — | 0.00 | 16.74 | 9.73 | 8.4 | ||||||
| EV/Sales | — | — | — | — | — | — | — | — | 10.90 | 10.73 | 2.76 | 10.8 | ||||||
| EV/FCF | — | — | — | — | — | — | — | — | (4.47) | (3.38) | (1.08) | (3.9) | ||||||
| Cash, $m | ||||||||||||||||||
| Cash, $m | Operating cash flow | — | — | — | — | — | — | — | — | (12) | (16) | (16) | +32.0% | |||||
| Capex | — | — | — | — | — | — | — | — | — | — | — | — | ||||||
| Free cash flow | — | — | — | — | — | — | — | — | (12) | (16) | (16) | +32.0% | ||||||
| Balance, $m | ||||||||||||||||||
| Balance, $m | Working capital | — | — | — | — | — | — | — | — | (26) | 2 | 0 | n/m | |||||
| Net debt | — | — | — | — | — | — | — | — | 5 | (10) | 1 | n/m | ||||||
| Shareholders’ equity | — | — | — | — | — | — | — | — | (24) | 4 | 2 | n/m | ||||||
| Returns, % | ||||||||||||||||||
| Returns, % | ROA | — | — | — | — | — | — | — | — | 0.00 | (155.84) | (268.26) | (155.8) pt | |||||
| ROIC | — | — | — | — | — | — | — | — | 0.00 | 0.00 | (410.80) | 0.0 pt | ||||||
| ROE | — | — | — | — | — | — | — | — | 0.00 | 134.30 | 106.08 | +134.3 pt | ||||||
| People | ||||||||||||||||||
| People | Employees | — | — | — | — | — | — | — | — | 75 | 75 | — | 0.0% | |||||
| Revenue/emp, $m | — | — | — | — | — | — | — | — | 0.06 | 0.07 | — | +12.5% | ||||||
Negative figures in brackets.
estimates
Fiscal years to Dec 2025 · latest quarter Jun 2026 · fundamentals updated 26 Oct 2026
Flag Ship Acquisition Corp vs peers in Medical Devices (Q) = latest quarter vs a year earlier
| Company | Market cap | P/E | Fwd P/E | Revenue growth (Q) | EPS growth (Q) | FCF growth (Q) | Gross margin (Q) | EBIT margin (Q) | Compare |
|---|---|---|---|---|---|---|---|---|---|
| NNOX Nano-X Imaging Ltd. | $19.6M | — (loss-making) | — (loss-making) | +36.71% (above 0%: growing) | n/m | −21.37% (below 0%: shrinking) | (1,050.87%) | (1,334.91%) | Compare |
| SNWV Sanuwave Health Inc. | $19.4M | 1.2× | — (loss-making) | −3.13% (below 0%: shrinking) | n/m | +86.75% (above 0%: growing) | 76.23% | (2.88%) | Compare |
| PMI Flag Ship Acquisition Corp | $19.3M | — (loss-making) | — (loss-making) | +38.62% (above 0%: growing) | n/m | +46.79% (above 0%: growing) | 20.85% | (156.70%) | |
| ALUR Allurion Technologies, Inc. | $16.7M | — (loss-making) | — (loss-making) | −47.19% (below 0%: shrinking) | n/m | +65.98% (above 0%: growing) | 41.70% | (126.60%) | Compare |
| LFWD Lifeward Ltd. | $16.3M | — (loss-making) | — (loss-making) | +15.71% (above 0%: growing) | n/m | −52.77% (below 0%: shrinking) | 40.90% | (62.69%) | Compare |
| ARAY Accuray Incorporated | $14.8M | — (loss-making) | — (loss-making) | −7.90% (below 0%: shrinking) | n/m | −138.30% (below 0%: shrinking) | 0.00% | (42.19%) | Compare |
| CTSO Cytosorbents Corporation | $14.5M | — (loss-making) | — (loss-making) | +0.17% (above 0%: growing) | n/m | +64.90% (above 0%: growing) | 73.18% | (27.39%) | Compare |
| RBOT Vicarious Surgical Inc. | $14.3M | — (loss-making) | — | — | n/m | +47.33% (above 0%: growing) | 0.00% | 0.00% | Compare |
| HSCS HeartSciences Inc. | $13.3M | — (loss-making) | — (loss-making) | −46.15% (below 0%: shrinking) | n/m | +18.18% (above 0%: growing) | 61.90% | (139,957.14%) | Compare |
| Median of peers | $15.5M | — | — | −3.13% | — | +32.76% | 41.30% | (52.44%) |
Pay and ownership Proxy statement filed 29 June 2026
Ownership
Directors and executive officers, together
0.00%
Hunniwell
39.62%
Hudson Bay Capital Management LP
6.99%
Ju Wang
5.27%
Ownership is the proxy’s own table: the directors and officers as a group, and every holder of 5% or more.
Read the proxy statement